A61K 39/00118
From embryonic or fetal origin
Official title: {from embryonic or fetal origin}
A61K39/00118 (From embryonic or fetal origin) appears on 191 US grants and 379 published applications in this corpus.
Search patents in A61K- Granted patents
- 191
- Published applications
- 379
- Assignees
- 181
- Inventors
- 592
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 7 |
| 2003 | 1 | 9 |
| 2004 | 3 | 10 |
| 2005 | 2 | 10 |
| 2006 | 0 | 10 |
| 2007 | 3 | 5 |
| 2008 | 3 | 8 |
| 2009 | 0 | 8 |
| 2010 | 2 | 11 |
| 2011 | 4 | 13 |
| 2012 | 7 | 14 |
| 2013 | 3 | 8 |
| 2014 | 7 | 14 |
| 2015 | 7 | 28 |
| 2016 | 10 | 28 |
| 2017 | 9 | 25 |
| 2018 | 13 | 31 |
| 2019 | 10 | 23 |
| 2020 | 15 | 19 |
| 2021 | 16 | 30 |
| 2022 | 19 | 22 |
| 2023 | 15 | 22 |
| 2024 | 13 | 12 |
| 2025 | 13 | 8 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nant cancer vaccine16 Jun 2026US 12,653,874 B2ImmunityBio, Inc.
- Compositions and methods for metal containing formulations capable of modulating immune response12 May 2026US 12,622,922 B2The Regents of the University of Michigan
- Polymeric nanovaccines and uses thereof3 Mar 2026US 12,564,643 B2Ramot at Tel-Aviv University Ltd.
- Methods of treating cancer3 Mar 2026US 12,565,682 B2NantCell, Inc.
- Bispecific antibodies against CEACAM5 and CD314 Oct 2025US 12,441,807 B2Lamkap Bio Alpha AG
- Cpg oligonucleotide and use thereof13 Aug 2026US 2026/0232792 A1Parr Biotechnology (Hebei) Co., Ltd.
- Methods of treating cancer4 Jun 2026US 2026/0152805 A1NantCell, Inc.
- Polymeric nanovaccines and uses thereof21 May 2026US 2026/0137804 A1Ramot at Tel-Aviv University Ltd.
- Bispecific antibodies against ceacam5 and cd323 Apr 2026US 2026/0109779 A1Lamkap Bio Alpha AG
- Chimeric cytokine receptor30 Oct 2025US 2025/0333538 A1Autolus Limited
Most cited
By later US patents
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same90US 5,891,432 AThe Immune Response Corporation · 1999
- Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen89US 6,265,189 B1Virogenetics Corporation · 2001
- Composition comprising a complexed (M)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof79US 9,572,874 B2CureVac AG · 2017
- Dock-and-lock (DNL) vaccines for cancer therapy68US 7,901,680 B2IBC Pharmaceuticals, Inc. · 2011